Candel Therapeutics Inc (CADL)

Other Income/Expenses (Net)

-$16.54M

TTM · Period ending: · USD

CADL logo

CADL Other Income/Expenses (Net)

Latest reported-$16.54M
CADL TTM Other Income/Expenses (Net) (-$3.87M → -$16.54M)
High-resolution chart · PNG

CADL other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-16,542,001
1,997,999
10,084,000
17,896,000
14,069,000
-5,978,000
-21,806,000
-16,651,000
-14,336,000
-705,000
452,000
4,247,000
4,014,000
8,653,000
15,927,000
22,245,000
13,919,000
-2,464,000
-10,397,000
-24,086,000
-15,758,000
-4,236,000
-3,869,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.